Metformin in Safety and Efficacy in Gouty Patients
Primary and study completion pushed from Nov 20, 2026 to Nov 20, 2027
Mostafa BahaaPhase 2 NCT06924658 Registry history of NCT06924658 on ClinicalTrials.gov (opens the registry)
4 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 2 with minor changes only.
Primary and study completion pushed from Nov 20, 2026 to Nov 20, 2027
Mostafa BahaaPhase 2 NCT06924658 Registry history of NCT06924658 on ClinicalTrials.gov (opens the registry)
Phase changed: Phase 3 → Phase 2
Also in this update: Recruitment opened
Mostafa BahaaPhase 2 NCT07800949 Registry history of NCT07800949 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Nov 20, 2026 to Aug 20, 2026
Mostafa BahaaPhase 2/3 NCT06113640 Registry history of NCT06113640 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 60 participants (planned 50); Primary completion date changed from estimate of Aug 20, 2027 to Aug 20, 2026
Mostafa BahaaPhase 2/3 NCT05986136 Registry history of NCT05986136 on ClinicalTrials.gov (opens the registry)
| Phase 2 | 3 | |
| Phase 3 | 1 |
Epilepsy (1)